13F History

Rhenman & Partners Asset Management AB

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024		-0.17%	$0	0	-701,707	-100%		Q3 2024
6/30/2024	0.17%		$1.8M	702K			$2.57	Q2 2024
3/31/2024	0.33%	+0.11%	$3.45M	702K	+225,835	+47.5%	$4.92	Q1 2024
12/31/2023	0.42%	+0.1%	$4.18M	476K	+114,193	+31.6%	$8.79	Q4 2023
9/30/2023	0.45%	+0.3%	$4.15M	362K	+238,679	+194%	$11.47	Q3 2023
6/30/2023	0.33%	-0.29%	$3.11M	123K	-107,000	-46.5%	$25.31	Q2 2023
3/31/2023	0.79%	-0.71%	$7.16M	230K	-208,000	-47.5%	$31.13	Q1 2023
12/31/2022	0.84%	+0.1%	$8.09M	438K	+50,000	+12.9%	$18.46	Q4 2022
9/30/2022	1%	-0.16%	$8.66M	388K	-62,000	-13.8%	$22.31	Q3 2022
6/30/2022	0.71%	+0.4%	$6.22M	450K	+251,642	+127%	$13.82	Q2 2022
3/31/2022	0.38%	+0.38%	$3.87M	198K	+198,358	NEW	$19.50	Q1 2022
12/31/2021		-0.63%	$0	0	-320,000	-100%		Q4 2021
9/30/2021	0.63%	+0.1%	$8.92M	320K	+50,000	+18.5%	$27.86	Q3 2021
6/30/2021	0.54%	+0.1%	$8M	270K	+50,000	+22.7%	$29.64	Q2 2021
3/31/2021	0.43%		$6.15M	220K			$27.95	Q1 2021
12/31/2020	0.51%		$6.24M	220K			$28.34	Q4 2020
9/30/2020	0.49%		$5.53M	220K			$25.14	Q3 2020
6/30/2020	0.58%		$5.37M	220K			$24.42	Q2 2020
3/31/2020	0.46%	-0.06%	$3.26M	220K	-30,000	-12%	$14.80	Q1 2020
12/31/2019	0.44%	+0.14%	$4.06M	250K	+76,083	+43.7%	$16.23	Q4 2019
9/30/2019	0.28%	-0.03%	$2.26M	174K	-19,264	-9.97%	$13.00	Q3 2019
6/30/2019	0.28%		$2.51M	193K			$12.97	Q2 2019
3/31/2019	0.36%		$3.05M	193K			$15.76	Q1 2019
12/31/2018	0.44%	-0.02%	$3.89M	193K	-10,000	-4.92%	$20.13	Q4 2018
9/30/2018	0.51%		$5.05M	203K			$24.85	Q3 2018
6/30/2018	0.57%		$5.58M	203K			$27.45	Q2 2018
3/31/2018	0.77%	+0.08%	$6.26M	203K	+20,601	+11.3%	$30.80	Q1 2018
12/31/2017	0.88%	-0.31%	$6.53M	183K	-63,820	-25.9%	$35.75	Q4 2017
9/30/2017	0.87%	+0.09%	$6.79M	246K	+26,400	+12%	$27.55	Q3 2017
6/30/2017	0.83%	+0.04%	$5.81M	220K	+10,000	+4.76%	$26.40	Q2 2017
3/31/2017	0.69%		$4.37M	210K			$20.80	Q1 2017
12/31/2016	0.83%		$4.35M	210K			$20.70	Q4 2016
9/30/2016	0.56%	-0.03%	$3.4M	210K	-10,000	-4.55%	$16.21	Q3 2016
6/30/2016	0.53%	+0.12%	$2.99M	220K	+50,000	+29.4%	$13.60	Q2 2016
3/31/2016	0.59%	-0.01%	$2.97M	170K	-3,000	-1.73%	$17.46	Q1 2016
12/31/2015	0.89%	+0.13%	$5.91M	173K	+25,000	+16.9%	$34.16	Q4 2015
9/30/2015	0.7%	-0.11%	$4.4M	148K	-24,000	-14%	$29.76	Q3 2015
6/30/2015	0.78%	-0.29%	$5.5M	172K	-64,000	-27.1%	$31.98	Q2 2015
3/31/2015	0.87%	+0.4%	$4.89M	236K	+109,426	+86.5%	$20.73	Q1 2015
12/31/2014	0.64%	+0.11%	$2.14M	127K	+21,319	+20.3%	$16.94	Q4 2014
9/30/2014	0.63%	+0.14%	$2.04M	105K	+23,255	+28.4%	$19.33	Q3 2014
6/30/2014	0.83%	+0.33%	$2.79M	82K	+32,865	+66.9%	$34.00	Q2 2014
3/31/2014	0.52%	+0.52%	$1.55M	49.1K	+49,135	NEW	$31.51	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.